APA

Sobol R. E., Royston I., Fakhrai H., Shawler D. L., Carson C., Dorigo O., Gjerset R., Gold D. P., Koziol J. & Mercola D. (19950608). Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study. : Human gene therapy.

Chicago

Sobol R E, Royston I, Fakhrai H, Shawler D L, Carson C, Dorigo O, Gjerset R, Gold D P, Koziol J and Mercola D. 19950608. Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study. : Human gene therapy.

Harvard

Sobol R. E., Royston I., Fakhrai H., Shawler D. L., Carson C., Dorigo O., Gjerset R., Gold D. P., Koziol J. and Mercola D. (19950608). Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study. : Human gene therapy.

MLA

Sobol R E, Royston I, Fakhrai H, Shawler D L, Carson C, Dorigo O, Gjerset R, Gold D P, Koziol J and Mercola D. Injection of colon carcinoma patients with autologous irradiated tumor cells and fibroblasts genetically modified to secrete interleukin-2 (IL-2): a phase I study. : Human gene therapy. 19950608.